Response to Letter to the Editor Regarding the Immunogenicity of Enhanced Influenza Vaccines in Inducing Neuraminidase Inhibition Antibodies
-
By
-
Pavithra Daulagala
-
Benjamin J Cowling
-
Hui-Ling Yen
-
January 24, 2026
-
0 min
Top Institutions in Infectious Disease
Brief introduction explaining scope and methodology.
-
#1
Centers for Disease Control and Prevention (CDC)
Atlanta, GA
Key Differentiators
- Infectious Diseases
- Immunology
- Vaccine Research
-
#2
National Institute of Allergy and Infectious Diseases (NIAID), NIH
Bethesda, MD
Key Differentiators
- Immunology
- Infectious Diseases
- Vaccine Development
-
#3
Johns Hopkins Bloomberg School of Public Health
Baltimore, MD
Key Differentiators
- Epidemiology
- Immunology
- Vaccine Research
-
#4
University of Michigan Medical School
Ann Arbor, MI
Key Differentiators
- Immunology
- Infectious Diseases
- Geriatric Medicine
-
#5
University of Oxford, Jenner Institute
Oxford, Oxfordshire
Key Differentiators
- Vaccine Research
- Immunology
- Infectious Diseases
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.